Tenet Healthcare (NYSE:THC) Stock Rating Upgraded by Wall Street Zen

Tenet Healthcare (NYSE:THC) was upgraded by analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a research note issued on Sunday.

Other analysts have also recently issued reports about the company. Leerink Partners increased their price target on Tenet Healthcare from $255.00 to $264.00 and gave the stock an “outperform” rating in a research report on Friday, February 20th. TD Cowen restated a “buy” rating on shares of Tenet Healthcare in a research note on Thursday, February 12th. Truist Financial raised their target price on Tenet Healthcare from $240.00 to $270.00 and gave the company a “buy” rating in a research note on Tuesday, February 17th. JPMorgan Chase & Co. upped their price target on shares of Tenet Healthcare from $200.00 to $230.00 and gave the stock an “overweight” rating in a research report on Thursday, November 13th. Finally, Guggenheim boosted their target price on shares of Tenet Healthcare from $257.00 to $271.00 and gave the company a “buy” rating in a research note on Friday, February 13th. One equities research analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $247.67.

Tenet Healthcare Stock Down 0.4%

THC stock opened at $238.68 on Friday. The firm has a market cap of $20.76 billion, a price-to-earnings ratio of 15.41, a PEG ratio of 1.18 and a beta of 1.44. Tenet Healthcare has a 1-year low of $109.82 and a 1-year high of $240.83. The firm has a fifty day moving average price of $206.02 and a two-hundred day moving average price of $199.95. The company has a debt-to-equity ratio of 2.18, a current ratio of 1.76 and a quick ratio of 1.68.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings results on Wednesday, February 11th. The company reported $4.70 EPS for the quarter, beating the consensus estimate of $4.08 by $0.62. The business had revenue of $5.53 billion during the quarter, compared to analyst estimates of $5.47 billion. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The company’s quarterly revenue was up 8.9% on a year-over-year basis. During the same period in the previous year, the business posted $3.44 EPS. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. Research analysts predict that Tenet Healthcare will post 12.24 EPS for the current year.

Insider Activity at Tenet Healthcare

In other news, Director Nadja West sold 2,178 shares of the business’s stock in a transaction on Monday, December 15th. The stock was sold at an average price of $197.47, for a total value of $430,089.66. Following the sale, the director owned 28,480 shares of the company’s stock, valued at approximately $5,623,945.60. The trade was a 7.10% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 0.81% of the company’s stock.

Institutional Investors Weigh In On Tenet Healthcare

Large investors have recently modified their holdings of the stock. Triumph Capital Management purchased a new stake in shares of Tenet Healthcare during the third quarter valued at $25,000. Activest Wealth Management purchased a new stake in Tenet Healthcare during the fourth quarter valued at about $26,000. Elyxium Wealth LLC acquired a new position in shares of Tenet Healthcare in the fourth quarter worth about $29,000. William B. Walkup & Associates Inc. purchased a new position in shares of Tenet Healthcare in the third quarter worth approximately $32,000. Finally, Canada Pension Plan Investment Board purchased a new stake in shares of Tenet Healthcare in the 2nd quarter valued at approximately $35,000. 95.44% of the stock is owned by institutional investors.

Key Stories Impacting Tenet Healthcare

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Zacks raised FY2026 EPS to $16.76 (from $15.41) — a meaningful upward revision to 2026 company-level earnings expectations. MarketBeat THC coverage
• Positive Sentiment: Q1 2026 EPS was increased to $4.14 (from $3.73), signalling stronger near-term operating performance. MarketBeat THC coverage
• Positive Sentiment: Q2 2026 EPS was raised to $4.10 (from $3.68), another near-term upward tweak. MarketBeat THC coverage
• Positive Sentiment: Zacks also lifted several quarterly 2026–2027 estimates (Q3 2026 to $4.08, Q4 2026 to $4.44, Q1 2027 to $4.31, and Q2 2027 slightly to $4.75), indicating expected stronger cadence through 2026 and into early 2027. MarketBeat THC coverage
• Positive Sentiment: Zacks published an FY2028 estimate of $17.80 EPS (new forward-year view), which supports a bullish longer-term earnings trajectory if achieved. MarketBeat THC coverage
• Negative Sentiment: Zacks cut FY2027 EPS to $16.35 from $17.98 — a notable decrease to next‑year full‑year expectations that can temper forward valuation. MarketBeat THC coverage
• Negative Sentiment: Q4 2027 was sharply lowered (to $3.28 from $4.82), representing the largest single-quarter downward revision and a driver of weaker medium-term visibility. MarketBeat THC coverage
• Negative Sentiment: Q3 2027 was reduced to $4.01 (from $4.38), another cut to later‑period quarterly expectations. MarketBeat THC coverage

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.